Disease volumes as a marker for patient response in malignant pleural mesothelioma

By Labby Z. E.   Nowak A. K.   Dignam J. J.   Straus C.   Kindler H. L.   Armato S. G.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 999-1005

Oxford University Press

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda  

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite

Malignant pleural mesothelioma

By Stahel Rolf A   Felley-Bosco Emanuela   Opitz Isabelle   Weder Walter  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma

By                  

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 21-28

Spandidos Publications

Access to resources Recommend Favorite

Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients

By                        

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 952-958

Spandidos Publications

Access to resources Recommend Favorite